Position in SVRA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,293,779
+$602,846 QoQ
Shares Held
372,367
+20.2% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 181 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. SVRA ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in SVRA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,293,779 | 372,367 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,690,933 | 309,695 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,886,604 | 312,870 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $975,880 | 273,356 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $614,429 | 269,487 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $728,329 | 262,935 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $778,642 | 253,630 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $999,621 | 235,760 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,161,948 | 288,325 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,275,790 | 256,183 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,389,793 | 295,701 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $988,223 | 261,435 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $692,655 | 216,794 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $99,882 | 51,222 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $79,393 | 51,222 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $133,575 | 86,178 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $130,990 | 86,178 | Shares | Defined | 2022-08-15 | |
| 2021-03-31 | $255,271 | 122,727 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $133,439 | 116,035 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $131,567 | 120,705 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $299,505 | 120,284 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $165,568 | 78,099 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||